We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CALIF. PBM DISCLOSURE BILL COULD RAISE PRICES, FTC SAYS
CALIF. PBM DISCLOSURE BILL COULD RAISE PRICES, FTC SAYS
September 24, 2004
Legislation pending in California that would require pharmaceutical benefit managers (PBMs) to disclose information about their transactions with drugmakers could raise the cost of drugs, according to recent analysis by the FTC.